Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Emcure Pharmaceuticals Community
NSEI:EMCURE Community
1
Narratives
written by author
0
Comments
on narratives written by author
1
Fair Values set
on narratives written by author
Community Investing Ideas
Emcure Pharmaceuticals
Popular
Undervalued
Overvalued
Emcure Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Expansion In Chronic Therapies And Emerging Markets Will Thrive
Key Takeaways Expansion in chronic therapies, specialty areas, and emerging markets is driving sustained revenue growth and broader international diversification. Strategic focus on high-margin products, robust R&D, and limited US exposure strengthen profitability, margin stability, and earnings resilience.
View narrative
₹1.65k
FV
9.6% undervalued
intrinsic discount
12.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
EMCURE
EMCURE
Emcure Pharmaceuticals
Your Fair Value
₹
Current Price
₹1.49k
8.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
141b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹141.1b
Earnings ₹12.8b
Advanced
Set Fair Value